register

ESG

New online resource for chronic pain patients

Health Industry Hub | October 28, 2019 |

A new online directory has been launched to provide people living with chronic pain – and their health practitioners – a comprehensive list of available services to help manage their conditions.

The National Pain Services Directory was developed by Painaustralia and supported by the Morrison Government.

The new directory will make it easier for people to access more than 200 pain treatment services, and ensure they are able to receive treatment that is appropriate and effective for their needs.

Deloitte Access Economics estimates 3.24 million Australians were living with chronic pain in 2018.

It is an escalating health issue and carries a significant economic burden, both for affected individuals and the national health system.

The Government funded Painaustralia to develop the National Strategic Action Plan for Pain Management. The Action Plan draws on best practice evidence as well as expertise from the pain sector to provide recommended actions for addressing the impact and burden of chronic pain.

$6.8 million has been invested to support a number of prominent pain activities, including:

  • $1 million to Painaustralia to support consumer awareness and education for people affected by pain.
  • $1 million to help train GPs to enable them to participate more effectively in pain management care.
  • $500,000 for a public education campaign specifically focused on the management of pain and the use of opioids.
  • $4.3 million to deliver outreach pain management specialist services in regional, rural and remote areas of Australia.

The National Pain Services Directory can be accessed from the Painaustralia website.

You may also like Osteoporosis Australia welcomes $4M for National Action Plan to enhance quality of care


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.